PSA Test: What It Is, When to Get One and What Results Mean

The PSA test is a valuable but complex tool for assessing prostate health. While it can help detect prostate cancer early, it can also cause unnecessary worry due to false positive results. This guide explains how the blood test works, who should consider taking it, and how modern medical pathways use MRI scans to safely guide your next steps without rushing to invasive procedures.

While the test can detect cancer early, it also has limitations, including false positives and the risk of over-diagnosis. Fortunately, medical practice has shifted towards a much smarter, less invasive diagnostic pathway. Today, we rely heavily on detailed MRI scans to clarify ambiguous results, and help us to decide when a biopsy is needed.

This guide is designed for men aged 45 and over, individuals in high-risk groups such as Black men or those with a family history of prostate cancer, trans women, and anyone wanting to understand the test. We will explain what PSA is, who should test, how to interpret your results, and what the modern pathway looks like if your result is high, helping you make an informed decision with your doctor.

What is the PSA test?

The PSA test is a blood test that measures the concentration of prostate-specific antigen in your blood. This specific protein is produced by both normal and cancerous cells in the prostate gland. By evaluating these protein levels, doctors can assess your overall prostate health and detect potential issues early.

Prostate-specific antigen (PSA)

It is normal to have a small amount of PSA circulating in your blood. The level of this protein can rise for many reasons, not all of which are related to cancer.

According to Prostate Cancer UK, the blood test simply measures the concentration of this specific protein in your bloodstream. Laboratory results are quantified in nanograms per millilitre (ng/mL). A higher number indicates a higher concentration of the antigen in your blood.

How the blood test works

The test itself is a very simple and quick procedure. A GP, nurse, or phlebotomist will draw a blood sample from a vein in your arm, much like any other routine blood test.

You do not need to fast before a PSA test. The sample is then sent off to a laboratory to be analysed. The physical process of giving the blood sample takes only a few minutes, making it an accessible first step for those evaluating their prostate health.

Who should have a PSA test?

You may consider having a PSA test if you are aged 50 or older, if you fall into a higher-risk category, or if you are experiencing symptoms related to your urinary tract or prostate. If you have symptoms it is best and safest to speak to doctor

Men over 50 with no symptoms

In the UK, the approach to PSA testing relies on informed choice.

The PHE Screening guidance explains that the UK National Screening Committee does not recommend a population-wide screening programme because there is not enough benefit to outweigh the potential harms of over-treatment for the general public.

People with prostate symptoms

We may advise a PSA test if a patient presents with specific urinary symptoms. You should speak to a clinician if you experience:

  • A frequent need to urinate, especially at night
  • A weak or interrupted urinary stream
  • Difficulty starting urination
  • A feeling that your bladder has not fully emptied

It is important to remember that these symptoms are common and are often caused by benign, non-cancerous conditions such as an enlarged prostate (known medically as benign prostatic hyperplasia, or BPH) but you will need to be checked as prostate cancer has similar symptoms.
If you have blood on your urine or semen see your GP so they can arrange tests you man needed.

Higher-risk groups

Some individuals have a statistically higher risk of developing prostate cancer and should consider discussing the test at an earlier age. According to the Prostate Cancer UK PSA Consensus 2024, we recommend discussions about testing from age 45 for:

  • Black men, who face a significantly higher risk of prostate conditions.
  • Men with a strong family history of prostate or breast cancer (such as a father or brother who developed the disease or are known to have the BRAC gene).

Trans women and non-binary people

Trans women and non-binary people who were assigned male at birth still have a prostate gland, even after gender-affirming surgery, and can still be at risk of prostate cancer. However, hormone therapy (such as oestrogen or testosterone blockers) can significantly lower PSA levels. This means your results must be carefully interpreted by a clinician who understands how these medications affect your baseline marker.

Pros and cons of PSA testing

The primary benefit of a PSA test is the potential to detect aggressive cancer at an early, treatable stage, while the main harms involve the anxiety of false positive results and the risk of treating slow-growing cancers that would never have caused harm.

Potential benefits

The most significant advantage of the PSA test is its ability to serve as an early warning marker. By finding an aggressive, life-threatening prostate cancer early, treatment is often much more effective and successful. For many patients, a normal result also provides more peace of mind and reassurance about their current health.

Potential harms and limitations

As noted in the GOV.UK summary guidance for GPs, the test is not perfect and comes with specific limitations. The table below outlines the key considerations:

Pros of the PSA test

Cons of the PSA test

Can detect aggressive cancer early when it is most treatable.

High chance of a false positive result, causing anxiety.

Provides reassurance if the result is normal.

Can lead to over-diagnosis of slow-growing, harmless cancers.

A simple, quick blood test with no immediate physical risks.

Unnecessary treatment can cause lasting side effects (e.g., erectile dysfunction, incontinence).

Could a baseline to monitor changes over time.

Can occasionally miss some types of prostate cancer (false negative).

If you have new symptoms and normal PSA it is still worth booking a GP appointment to discuss causes.

Preparation for a PSA test

To ensure your PSA test result is reliable, avoid certain activities that can temporarily irritate the prostate and artificially inflate your protein levels for at least 48 hours before your blood test.

Factors that raise PSA levels

The prostate gland is sensitive. Everyday activities that put pressure on the gland or stimulate it can cause it to release more prostate-specific antigen into the blood. If this happens right before your test, your result may appear abnormally high, leading to unnecessary worry.

Common factors that artificially raise your PSA include recent ejaculation, vigorous exercise that puts pressure on the pelvic area (especially cycling), having a urinary tract infection (UTI), having a urinary catheter fitted, or undergoing any form of prostate stimulation, including a digital rectal exam by a doctor. Also some medicationstons can also affect PSA so important to discuss this with your GP e.g finasteride

48-hour pre-test checklist

To give your clinical team the most accurate diagnostic picture, we recommend following specific preparation steps. According to patient advice from BAUS, you should follow this checklist for at least 48 hours before your blood draw:

  • Avoid any sexual activity that results in ejaculation.
  • Avoid vigorous exercise, particularly cycling or activities that apply direct pressure to the perineum.
  • Inform your clinician if you have had a suspected urinary infection within the last six weeks.
  • Tell your doctor if you have had any recent medical procedures involving your bladder or prostate.

Understanding your PSA test results

Your PSA test result is a numerical value that a clinician will evaluate alongside your age, prostate size, symptoms, and medical history to determine if further investigation is needed.

Normal PSA levels

There is no single 'normal' PSA level that applies to everyone. As you get older, your prostate gland naturally enlarges, meaning your baseline PSA level will naturally increase with age. Because of this, clinicians use age-specific reference ranges to evaluate whether a result is unusually elevated.

This can vary based on labs and local policy. Check your local guidance.

An example table:

Age group

Typical PSA level reference range

40 to 49 years

Less than 2.5 ng/mL

50 to 59 years

Less than 3.5 ng/mL

60 to 69 years

Less than 4.5 ng/mL

70 years and over

Less than 6.5 ng/mL

Non-cancerous causes of high PSA

It is crucial to understand that a raised PSA result is not a diagnosis of cancer. As outlined by the NHS, many benign factors cause elevated readings.

The most common cause is benign prostatic hyperplasia (BPH), which is a normal, non-cancerous enlargement of the prostate as you age. Another frequent cause is prostatitis, which is an inflammation or infection of the prostate gland. Additionally, if you did not follow the 48-hour preparation guidance regarding exercise or ejaculation, your results may be temporarily elevated.

PSA density and free PSA

If your initial result is ambiguous, a specialist might use secondary metrics to build a more detailed picture of your risk without moving straight to a physical procedure.

Metric

What it measures

How it helps clinicians

PSA Density

Compares your PSA level to the physical volume (size) of your prostate.

Helps indicate if a high reading is less concerning because it is caused by a very large, benign prostate.

Free PSA

The ratio of unattached (floating freely) PSA to total PSA in the blood.

A lower percentage can be more indicative of cancer, while a higher percentage usually points to benign conditions.

What happens after a high PSA result?

A high PSA result may mean a physical biopsy is needed/; You also have advanced MRI scans to safely guide your next steps which your doctor will decide and discuss with you..

Step 1: Ruling out infection and repeating the test

If your first PSA reading is high, your GP may refer you for cancer investigations immediately. Or in some cases the next step is to rule out temporary causes. Your doctor will likely ask for a urine sample to check for an underlying urinary tract infection. If your urine is clear, standard practice is to wait four to six weeks and then schedule a second PSA test to see if the levels have stabilised, fallen, or continued to rise.

Step 2: Referral and the crucial role of an mp MRI scan

If your repeat PSA level remains high or your GP has other clinical concerns, they will refer you to a specialist. The standard next step is usually a multi-parametric MRI (mpMRI) scan of the prostate.

An mpMRI is a specialised type of scan that creates highly detailed images of the prostate tissue. Its primary purpose is to identify any suspicious lesions or areas that might contain clinically significant cancer. The greatest benefit of this modern pathway is reassurance: if your mpMRI scan shows a clear, normal-looking prostate, you can often safely avoid an invasive biopsy altogether.

Step 3: When is a prostate biopsy needed?

The doctor will decide what is best for you based on your symptoms, health conditions and medications. They will discuss these with you along with the tests.

A biopsy, which involves taking small tissue samples from the prostate for laboratory analysis, is usually recommended if the mpMRI scan highlights a suspicious area.

If you do need a biopsy, the detailed MRI images help to guide the procedure. This is known as a fusion biopsy. By overlaying the MRI scan onto a live ultrasound, a specialist can precisely target the suspicious tissue,. For more detailed information on this process, you can read our guide to Prostate MRI and Biopsy Procedures.

What is active surveillance?

Active surveillance is a structured, proactive monitoring strategy used for slow-growing, low-risk prostate cancers to safely delay or avoid treatment side effects.

When a biopsy detects prostate cancer, patients often assume they need immediate surgery or radiotherapy. However, many prostate cancers grow so slowly that they will never cause symptoms or shorten a person's life. In these cases, immediate treatment may do more harm than good and the best approach for you will depend on many factors

Active surveillance vs. watchful waiting

While they sound similar, active surveillance and watchful waiting are different clinical approaches based on your health profile and the nature of the cancer.

Approach

Best for

Primary Goal

Treatment Trigger

Active Surveillance

Individuals with low-risk, curable cancer.

To monitor disease closely and safely delay treatment side effects.

Curative treatment is initiated if the cancer grows or changes.

Watchful Waiting

Older patients or those with other significant health issues.

To manage symptoms and maintain quality of life.

Symptom management is initiated as issues arise.

The monitoring process

If you and your specialist decide on active surveillance, you will enter a strict, regular monitoring schedule. This typically involves having your PSA levels tested every three to six months.

You will also be scheduled for repeat MRI scans, and sometimes repeat biopsies, check the physical state of the prostate based on the specialist protocols. This watchful approach allows thousands of men to safely maintain their quality of life and arrange more tests when needed. This aims to avoid unnecessary procedures, urinary incontinence and erectile dysfunction.

Conclusion

Navigating prostate health can feel overwhelming, but understanding the tools available to you is an important first step. Being informed allows you to take control of your health. The next step is to have an open, unhurried conversation with a doctor about what is right for your specific circumstances.

If you are concerned about your prostate health, want to discuss your personal risk factors, or need support understanding a recent result, book an appointment with a Doctor Care Anywhere GP today for a confidential and personalised consultation.

See a UK GP today

Skip the wait — book an online appointment and get expert advice from a UK-registered clinician in as little as 2 hours.

Frequently asked questions

 

 

There is no single PSA level that is considered dangerous for everyone. The NHS notes that the context of your result is key. A clinician assesses risk based on your PSA level relative to your age, how quickly the number is changing over time (known as PSA velocity), and the physical findings from an MRI scan.

There are no proven ways to lower your PSA level naturally if it is clinically high. While maintaining a healthy diet and regular exercise supports general prostate health, Prostate Cancer UK emphasises that patients should focus on diagnosing the underlying cause with a doctor rather than trying unproven remedies to alter a blood test result.

There isn't a national screening programme for prostate cancer in the UK because PHE Screening guidance states that the potential harms — specifically over-diagnosis and the resulting over-treatment of harmless cancers — currently outweigh the benefits for a population-wide programme. PSA screening by the NHS is recommended for specific groups. PSA screening may change so check the nhs website.

A digital rectal exam (DRE) is still sometimes needed alongside a PSA test as a complementary diagnostic tool. While some dangerous prostate cancers do not release enough protein to raise your PSA significantly, they can sometimes be felt as a hard lump during a physical exam depending on the location. Because of this, a doctor may recommend both tests for a more complete clinical assessment.


 


You need to abstain from ejaculation for at least 48 hours before a PSA test. As advised by BAUS, avoiding sexual activity that results in ejaculation prevents your reading from being temporarily and artificially raised, ensuring your clinical team gets the most accurate diagnostic picture from your blood sample.